Pharmacists Manitoba Conference
Safety IQ: A Community Perspective
Doug Thidrickson, B.Sc. (Pharm), CTH, Store Manager, Ashern Pharmacy
Doug Thidrickson is currently the pharmacy manager of Ashern Pharmacy. His diverse work experience includes working retail and hospital practice in Minneapolis and Manitoba within multiple health networks. Regardless of the practice setting, he has witnessed the serious consequences of medication errors and the tools to mitigate them. With participation in the Safety IQ project, he continues to incorporate this culture of safety into his community practice. This presentation shares the challenges and opportunities to improve patient safety at the community pharmacy level.
Session
This presentation describes the components of Safety IQ including incident reporting and analysis, medication safety self-assessment and continuous quality improvement.The Safety IQ community experience will be shared with participants including the challenges and tools to overcome these challenges.Finally, there will be an interactive opportunity to apply these tools to real life scenarios.Participants will be able to more confidently incorporate the components of Safety IQ into their daily practice to improve patient safety.
The Pharmacist's Role in Managing Pain In An Era of Opioid Avoidance
Philip Emberley, BSc. (Pharm.), MBA, PharmD, Director, Practice Advancement and Research, Canadian Pharmacists Association
Phil Emberley, BSc.(Pharm.), MBA, PharmD, is the Director of Practice Advancement and Research at the Canadian Pharmacists Association. Phil obtained his BSc.(Pharm.) from the University of British Columbia, and his PharmD from the University of Washington. For the last six years, he has led CPhA through the expansion of its continuing professional development program for pharmacists, which includes the highly successful ADAPT program. Phil is also a member of the Task Group on Specialization in Pharmacy in Canada, a board member of the Canadian Council on Continuing Education in Pharmacy. Phil is also a member of a number of committees and task forces with the aim of promoting the value of pharmacists as accessible primary care providers, most notably the Education Implementation Committee of Canada’s First Do No Harm Strategy.
Phil’s prior experience as a front-line pharmacist, pharmacist-owner and corporate manager provides a pragmatic approach to fostering pharmacy practice change.
Phil also has extensive experience in health policy, having worked as a consultant with the Ministry of Health Services, Government of British Columbia, in the area of Formulary Management and Special Authority. This experience has given him insights into current hot button issues such as health system sustainability, National Pharmacare and the optimal use of medication.
Session
Pharmacists have an intrinsic role to play in supporting their patients who present with either acute or chronic pain.In an era when the risks of opioid treatment are seemingly ubiquitous, pharmacists must help their patients effectively manage their pain, while preventing them from these risks.More specifically, pharmacists are now being called on to question the necessity of starting a patient on an opioid (and suggest alternatives if appropriate) and to help patients withdraw from opioid therapy when the risks outweigh the benefits.This session will take an evidence-based approach to therapeutic decision making and suggest strategies to working collaboratively with patients and prescribers in minimizing the risk to patients, while effectively supporting optimal pain management.